Actively Recruiting
Study of Adults with Long COVID Symptoms in a Specialized Care Program to Identify Clinical Profiles and Biomarkers
Led by Hospices Civils de Lyon · Updated on 2026-01-21
150
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients with Post-Acute COVID-19 Syndrome who have ongoing or complex symptoms lasting more than 4 weeks or 3 months after documented SARS-CoV-2 infection. The study aims to identify clinical profiles of these long-COVID patients and link them with immunological and molecular data to find prognostic biomarkers and possible treatment targets. Participants are adults aged 18 years or older who join either a post-COVID rehabilitation program or the EPSILON care pathway. During a single inclusion visit, clinical and biological data are collected, including a one-time 30 mL blood sample for immunological and molecular analysis. No therapeutic intervention is given, and samples are analyzed without storage after testing. During the visit, researchers gather detailed clinical and biological information to classify participants into clinical clusters based on symptoms and other data. They measure residual viral proteins and serum biomarkers to understand differences between patient groups. The main outcome is the number of participants in each clinical cluster at the time of inclusion. The study monitors patients profiles at this single time point, with no long-term follow-up specified. The study is led by Hospices Civils de Lyon and will run until June 2026.
CONDITIONS
Brief Title
Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort
Research Team
S
Sébastien Couraud, Pr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here